An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Clinical trial NCT01932125 · COMPLETED

Trial details

NCT number: NCT01932125
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ovarian Neoplasms Peritoneal Neoplasms Fallopian Tube Neoplasms

Start date: 2018-12-05
Primary completion: 2025-06-18
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.